Fintel reports that on May 26, 2026, Raymond James upgraded their outlook for Tectonic Therapeutic (NasdaqGM:TECX) from Outperform to Strong Buy.
Analyst Price Forecast Suggests 172.83% Upside
As of May 14, 2026, the average one-year price target for Tectonic Therapeutic is $79.45/share. The forecasts range from a low of $60.60 to a high of $106.05. The average price target represents an increase of 172.83% from its latest reported closing price of $29.12 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Tectonic Therapeutic is 0MM. The projected annual non-GAAP EPS is -4.54.
What is the Fund Sentiment?
There are 122 funds or institutions reporting positions in Tectonic Therapeutic. This is an decrease of 57 owner(s) or 31.84% in the last quarter. Average portfolio weight of all funds dedicated to TECX is 0.12%, an increase of 70.95%. Total shares owned by institutions increased in the last three months by 3.01% to 14,446K shares. 
The put/call ratio of TECX is 0.07, indicating a bullish outlook.
What are Other Shareholders Doing?
TCG Crossover Management holds 1,205K shares representing 6.39% ownership of the company.
Standard Life Aberdeen holds 1,142K shares representing 6.05% ownership of the company. No change in the last quarter.
Braidwell holds 847K shares representing 4.49% ownership of the company. In its prior filing, the firm reported owning 928K shares , representing a decrease of 9.49%. The firm increased its portfolio allocation in TECX by 41.17% over the last quarter.
First Light Asset Management holds 648K shares representing 3.43% ownership of the company. In its prior filing, the firm reported owning 0K shares , representing an increase of 100.00%.
Baker Bros. Advisors holds 608K shares representing 3.22% ownership of the company. In its prior filing, the firm reported owning 903K shares , representing a decrease of 48.64%. The firm decreased its portfolio allocation in TECX by 2.24% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
